The Consumer Affairs Agency announced on 7 June 2024 that it had issued an Order for Action to a medical corporation in Tokyo for violating Article 5, Item 3 of the Act Against Unjustifiable Premiums and Misleading Representations for engaging in “stealth marketing.” The corporation had been providing its customers with discounts in exchange for favorable reviews on its website. This is the first time that the Consumer Affairs Agency has issued a stealth marketing-related Order for Action.

Related

Practice Focus